![A Guide to Drug Development for Biologics: Overcoming Formulation and Manufacturing Challenges | LLS Health CDMO A Guide to Drug Development for Biologics: Overcoming Formulation and Manufacturing Challenges | LLS Health CDMO](https://lubrizolcdmo.com/wp-content/uploads/2021/01/Biologics-Header-Image.png)
A Guide to Drug Development for Biologics: Overcoming Formulation and Manufacturing Challenges | LLS Health CDMO
![AbbVie's drug Humira losing its patent protection. Humira is abbvie's best selling drug in terms of revenue by a big margin. Should we expect pressure on the dividends as biosimilars are released AbbVie's drug Humira losing its patent protection. Humira is abbvie's best selling drug in terms of revenue by a big margin. Should we expect pressure on the dividends as biosimilars are released](https://external-preview.redd.it/WW2FshdyF3RBbM7HKidjzlnGY-FUsKYGheKes_m58oM.jpg?auto=webp&s=0d12bf3b64b8585aa78ac30890cb5207e144e3b5)
AbbVie's drug Humira losing its patent protection. Humira is abbvie's best selling drug in terms of revenue by a big margin. Should we expect pressure on the dividends as biosimilars are released
![File:Development of better monoclonal antibodies for human therapy and their nomenclature.svg - Wikimedia Commons File:Development of better monoclonal antibodies for human therapy and their nomenclature.svg - Wikimedia Commons](https://upload.wikimedia.org/wikipedia/commons/thumb/a/af/Development_of_better_monoclonal_antibodies_for_human_therapy_and_their_nomenclature.svg/2560px-Development_of_better_monoclonal_antibodies_for_human_therapy_and_their_nomenclature.svg.png)